Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI

NCT02298660 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rick Hansen Institute

Collaborators